Analysis for VRTX
- 📈 Growth — 22/30
- 💰 Profitability — 18/20
- 🏦 Financial Health — 18/20
- 💵 Valuation — 15/20
- ⚠️ Risk — 6/10
Summary:
📈 Growth & Financial Trajectory
Vertex shows an eight-quarter trajectory from 2024-Q2 to 2026-Q1 with revenue rising from about $2.645B to around $2.987B and then a modest dip in 2026-Q1. Net income swings from a sizable loss in 2024-Q2 to a positive gain of about $1.031B by 2026-Q1, signaling a substantial earnings turnaround. Gross margins remain exceptionally high, typically in the 83-95% range, underpinning durable profitability. In late quarters, operating income tracks revenue and, in 2026-Q1, demonstrates a robust margin with operating income near $1.14B on about $2.99B in revenue, translating to a healthy operating margin.
💰 Margins & Cash Flow
- Gross Margin around 83-95% across periods.
- Operating Margin generally in the high 30s% range in recent quarters.
- Net cash flow from operating activities is consistently positive, notably about $1.14B–$1.43B in later quarters; investing and financing activity reflect ongoing R&D and pipeline investments.
🛡️ Balance Sheet & Liquidity
Total assets run in the $22B–$26B band with equity around $16B–$19B. Current assets near $9B–$11B vs current liabilities of roughly $3.5B–$4.1B, pointing to solid liquidity. Leverage remains manageable, and the strong equity cushion supports ongoing development.
⚠️ Key Drivers & Risks
- Drivers: Robust gross margins and strong cash generation enable continuous R&D and pipeline advancement.
- Risks: Pipeline execution, regulatory/pricing dynamics, and revenue sensitivity to approvals/competition.